Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Improvements in extraintestinal manifestations with vedolizumab treatment in a real-world cohort of patients with Inflammatory Bowel Disease (IBD) are shown, demonstrating that vedolizumab was effective on extraintestinal manifestations in patients with Bowel Disease (IBD) and with concomitant Extraintestinal Manifestations while demonstrating a good safety profile.
see also:
Anti-integrins / Integrin inhibitors & Inflammatory Bowel Disease (IBD)
…